|
TIGD7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.86509713123928E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.417030E-01 |
| Stage1-vs-Stage3 |
1.018380E-02 |
| Stage1-vs-Stage4 |
7.402100E-04 |
| Stage2-vs-Stage3 |
5.759100E-03 |
| Stage2-vs-Stage4 |
4.979400E-04 |
| Stage3-vs-Stage4 |
2.067000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.33500005178911E-09 |
| Normal-vs-Asian |
1.62536650805123E-12 |
| Caucasian-vs-AfricanAmerican |
3.312800E-01 |
| Caucasian-vs-Asian |
2.397800E-01 |
| AfricanAmerican-vs-Asian |
9.230400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.610800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.00680000003628E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.348600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.483700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.660600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.496400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.593800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.885000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.82789999999544E-05 |
| Classical-VS-Follicular |
4.178600E-01 |
| Classical-VS-Other |
9.238600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.42869999999007E-05 |
| Tall-VS-Other |
2.408200E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
8.720400E-01 |
| Follicular-VS-Normal |
1.62492241884138E-12 |
| Other-VS-Normal |
9.65750000000432E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.149700E-02 |
|
|
